Ensuring well-being and quality of life is the top priority in the care of any oncology patient. However, the use of morphine is often surrounded by fears and taboos that cause unnecessary distress for both patients and their families. To address this topic with the utmost clarity and medical rigor, this article has been developed with the review and collaboration of Dr. Esther Martín Holgado, an oncologist at GenesisCare and member of the IVOQA team, who helps us debunk these myths and understand the true role of this treatment as a vital tool for pain management.
When is it actually prescribed, and why should you not fear it?
The term morphine frequently generates concern among oncology patients and their families. It is often erroneously associated with the end-of-life stages or the idea that treatment is no longer effective.
From a medical perspective, the indication for morphine depends exclusively on the intensity of the pain and its functional impact, rather than the prognosis or the stage of the cancer.
What is morphine and what is its role in cancer treatment?
Morphine is a major opioid analgesic indicated for the treatment of moderate to severe pain when non-opioid or weak opioid analgesics fail to provide adequate control.
In oncology, its primary goal is to ensure proper pain management, allowing patients to maintain their quality of life, preserve functional capacity, and continue their oncological treatments in the best possible condition.
Myth #1: “Morphine is only prescribed in terminal phases”
No.
Morphine is prescribed at any stage of the oncological disease if the pain requires it. Its indication is based on the WHO analgesic ladder, a progressive therapeutic model that adjusts treatment to the patient’s pain level. Adequate analgesic control reduces physiological stress, improves rest, mobility, and nutritional status, contributing to the patient’s overall well-being.
Myth #2: “Morphine causes addiction”
In oncology patients treated under medical supervision, the risk of addiction is very low.
What may develop over time is pharmacological tolerance, which implies the need to adjust the dose to maintain the analgesic effect. The dosage, adjustments, and withdrawal of treatment are always carried out in an individualized and progressive manner, minimizing risks and side effects.
Side Effects: What they are and how they are managed
The side effects of morphine are well-known, predictable, and, in most cases, easily controlled:
- Constipation: A virtually universal effect; it is systematically prevented with laxatives.
- Drowsiness: Common at the start of treatment; it usually subsides after the first few days.
- Nausea and Vomiting: Manageable with antiemetic treatment.
Clinical follow-up allows healthcare providers to anticipate these effects and adjust the treatment to ensure maximum tolerability.
A Multidisciplinary Approach to Cancer Pain
Pain management is an essential part of the comprehensive treatment for cancer patients.
Oncology teams, pain units, and palliative care specialists work in a coordinated manner to individualize analgesic treatment, improve quality of life, and avoid unnecessary suffering at any stage of the disease. Morphine and its derivatives, under medical prescription and indication, are highly effective tools within this global and personalized approach.
